Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CELLEGY PHARMACEUTICALS INC | 50,000 | reported | 26 Aug 2019 | tx 1+50,000 |
| OnKure Therapeutics, Inc. | 14,815 | reported | 06 Jun 2023 | tx 2+49,815 |
| Kronos Bio, Inc. | 0 | reported | 20 Jun 2025 | tx 8+143,200−143,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 41,200 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | OnKure Therapeutics, Inc. | 14,815 | 0.00 USD | deriv |
| 02 Aug 2022 | GRANT_AWARD | OnKure Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 11 Nov 2021 | GRANT_AWARD | Kronos Bio, Inc. | 41,200 | 0.00 USD | deriv |
| 26 Aug 2019 | GRANT_AWARD | CELLEGY PHARMACEUTICALS INC | 50,000 | 0.00 USD | deriv |